Penumbra Inc
PEN293.830USD
+0.990+0.34%
交易中 （美东）报价延迟15分钟
11.37B总市值
811.19市盈率 TTM
关于 Penumbra Inc 公司
Penumbra, Inc. 是一家医疗保健公司。该公司设计、开发、制造和销售产品，并拥有一系列产品，可解决市场上尚未满足需求的棘手医疗状况。该公司专注于开发、制造和销售供专科医生和医疗保健提供者使用的产品，以推动改善临床和健康结果。该公司专注于开发和构建其产品组合，包括血栓切除术、栓塞术、通路和沉浸式医疗保健技术。该公司关注的常见疾病包括肺栓塞、深静脉血栓形成、外周动脉闭塞、缺血性中风、急性冠状动脉综合征、与动静脉移植或瘘相关的血栓、动脉瘤和出血性中风。该公司主要通过其在美国、欧洲、加拿大和澳大利亚的直销组织以及在特定国际市场的分销商向医疗保健提供者销售其产品。
公司简介
公司代码PEN
公司名称Penumbra Inc
上市日期Sep 18, 2015
成立日期2004
CEOMr. Adam Elsesser, J.D.
员工数量4500
证券类型Ordinary Share
年结日Sep 18
公司地址One Penumbra Place
城市ALAMEDA
上市交易所NYSE Consolidated
国家United States of America
邮编94502
电话15109952486
网址https://www.penumbrainc.com/
公司代码PEN
上市日期Sep 18, 2015
成立日期2004
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Adam Elsesser, J.D.
Mr. Adam Elsesser, J.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
901.49K
+4.18%
Dr. Arani Bose, M.D.
Dr. Arani Bose, M.D.
Director
Director
302.26K
-3.82%
Ms. Johanna Roberts
Ms. Johanna Roberts
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
53.58K
-0.36%
Mr. Lambert Shiu
Mr. Lambert Shiu
Chief Accounting Officer
Chief Accounting Officer
25.61K
-4.98%
Ms. Janet Leeds
Ms. Janet Leeds
Independent Director
Independent Director
5.49K
-1.06%
Ms. Bridget O'Rourke
Ms. Bridget O'Rourke
Independent Director
Independent Director
4.96K
-1.00%
Ms. Surbhi Sarna
Ms. Surbhi Sarna
Independent Director
Independent Director
3.15K
-1.84%
Ms. Maggie S. Yuen
Ms. Maggie S. Yuen
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Thomas C. (Tom) Wilder, III
Mr. Thomas C. (Tom) Wilder, III
Presiding Independent Director
Presiding Independent Director
--
--
Mr. Harpreet S. Grewal
Mr. Harpreet S. Grewal
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Adam Elsesser, J.D.
Mr. Adam Elsesser, J.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
901.49K
+4.18%
Dr. Arani Bose, M.D.
Dr. Arani Bose, M.D.
Director
Director
302.26K
-3.82%
Ms. Johanna Roberts
Ms. Johanna Roberts
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
53.58K
-0.36%
Mr. Lambert Shiu
Mr. Lambert Shiu
Chief Accounting Officer
Chief Accounting Officer
25.61K
-4.98%
Ms. Janet Leeds
Ms. Janet Leeds
Independent Director
Independent Director
5.49K
-1.06%
Ms. Bridget O'Rourke
Ms. Bridget O'Rourke
Independent Director
Independent Director
4.96K
-1.00%
收入明细
单位: USD更新时间: 4月6日 周日
单位: USD更新时间: 4月6日 周日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Thrombectomy
815.48M
68.26%
Embolization and Access
379.14M
31.74%
地区USD
名称
营收
占比
United States
902.07M
75.51%
International
292.55M
24.49%
业务
地区
业务USD
名称
营收
占比
Thrombectomy
815.48M
68.26%
Embolization and Access
379.14M
31.74%
股东统计
更新时间: 4月26日 周六
更新时间: 4月26日 周六
持股股东
股东类型
持股股东
股东统计
占比
Fidelity Management & Research Company LLC
12.53%
The Vanguard Group, Inc.
9.41%
BlackRock Institutional Trust Company, N.A.
9.03%
Champlain Investment Partners, LLC
3.86%
T. Rowe Price Associates, Inc.
3.19%
Other
61.98%
持股股东
股东统计
占比
Fidelity Management & Research Company LLC
12.53%
The Vanguard Group, Inc.
9.41%
BlackRock Institutional Trust Company, N.A.
9.03%
Champlain Investment Partners, LLC
3.86%
T. Rowe Price Associates, Inc.
3.19%
Other
61.98%
股东类型
股东统计
占比
Investment Advisor
50.51%
Investment Advisor/Hedge Fund
32.26%
Hedge Fund
4.42%
Individual Investor
3.42%
Research Firm
1.59%
Pension Fund
1.51%
Sovereign Wealth Fund
0.68%
Bank and Trust
0.54%
Private Equity
0.19%
Other
4.87%
机构持股
更新时间: 1月20日 周一
更新时间: 1月20日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q1
838
36.86M
95.18%
-4.14M
2024Q4
834
37.02M
96.10%
-3.78M
2024Q3
813
37.33M
96.12%
-2.93M
2024Q2
796
37.57M
96.93%
+395.13K
2024Q1
777
35.67M
92.18%
-2.09M
2023Q4
759
36.33M
94.13%
-67.98K
2023Q3
737
35.15M
91.46%
-2.09M
2023Q2
719
36.20M
94.64%
-1.94M
2023Q1
681
37.31M
97.62%
-964.82K
2022Q4
661
36.89M
97.22%
+885.45K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Fidelity Management & Research Company LLC
4.85M
12.6%
-93.71K
-1.89%
Dec 31, 2024
The Vanguard Group, Inc.
3.64M
9.46%
-25.90K
-0.71%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
3.50M
9.08%
+25.93K
+0.75%
Dec 31, 2024
Champlain Investment Partners, LLC
1.50M
3.88%
-52.02K
-3.36%
Dec 31, 2024
T. Rowe Price Associates, Inc.
1.23M
3.21%
-702.67K
-36.27%
Dec 31, 2024
State Street Global Advisors (US)
1.20M
3.12%
-33.45K
-2.71%
Dec 31, 2024
Fidelity Institutional Asset Management
965.15K
2.51%
+16.18K
+1.71%
Dec 31, 2024
Elsesser (Adam)
985.33K
2.56%
+22.75K
+2.36%
Mar 19, 2025
William Blair Investment Management, LLC
883.10K
2.29%
-98.21K
-10.01%
Dec 31, 2024
RTW Investments L.P.
862.45K
2.24%
+66.70K
+8.38%
Dec 31, 2024
查看更多
持股ETF
更新时间: 4月6日 周日
更新时间: 4月6日 周日
机构名称
占比
Motley Fool Small-Cap Growth ETF
3.6%
First Trust Health Care Alphadex Fund
2.08%
First Trust Indxx Medical Devices ETF
1.89%
Congress SMid Growth ETF
1.87%
Putnam Sustainable Future ETF
1.67%
Tema Neuroscience and Mental Health ETF
1.58%
ROBO Global Healthcare Technology & Innovation ETF
1.56%
SPDR S&P Health Care Equipment ETF
1.53%
Zacks Focus Growth ETF
1.2%
iShares U.S. Medical Devices ETF
1.13%
查看更多
Motley Fool Small-Cap Growth ETF
占比3.6%
First Trust Health Care Alphadex Fund
占比2.08%
First Trust Indxx Medical Devices ETF
占比1.89%
Congress SMid Growth ETF
占比1.87%
Putnam Sustainable Future ETF
占比1.67%
Tema Neuroscience and Mental Health ETF
占比1.58%
ROBO Global Healthcare Technology & Innovation ETF
占比1.56%
SPDR S&P Health Care Equipment ETF
占比1.53%
Zacks Focus Growth ETF
占比1.2%
iShares U.S. Medical Devices ETF
占比1.13%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据